NCT03220841 - Stricture Definition and Treatment (STRIDENT) Drug Therapy Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 9, 2017

Primary Completion Date

September 18, 2020

Study Completion Date

September 30, 2021

Conditions

Crohn DiseaseInflammatory Bowel DiseasesStricture; Bowel

Interventions

DRUG

Adalimumab Injection

Standard dose adalimumab induction and maintenance

DRUG

Thiopurine

Dose optimized thiopurine

PROCEDURE

Endoscopic balloon dilatation

Prior to randomization, suitable patients may undergo endoscopic balloon dilatation. Patients undergoing dilatation will be stratified to ensure equal numbers in each study arm.

Trial Locations (1)

3065

St. Vincent's Hospital Melbourne, Melbourne